港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

2,233.977

-0.696-0.03%

漲家數：5

跌家數：2

平家數：1

市盈率：- -

高：2,278.270

開：2,235.125

低：2,232.626

收：2,234.673

資料載入中...

復星醫藥子公司啓動復邁寧®兒童腦膠質瘤Ⅲ期臨牀試驗

每日賣空追蹤 | 康龍化成 07月09日賣空量成交15.08萬股，賣空比例為1.51%

每日賣空追蹤 | 泰格醫藥 07月09日賣空量成交85.54萬股，賣空比例為7.74%

每日賣空追蹤 | 藥明生物 07月09日賣空量成交489.7萬股，賣空比例為12.91%

每日賣空追蹤 | 藥明康德 07月09日賣空量成交38.06萬股，賣空比例為9.38%

每日賣空追蹤 | 金斯瑞生物科技 07月09日賣空量成交264.6萬股，賣空比例為5.9%

維亞生物07月09日獲主力加倉59.9萬元

微芯生物(688321.SH)：西達本胺一線治療瀰漫大B細胞淋巴瘤的III期臨牀試驗獲頂線分析數據

藥明生物(02269)出現大手賣出24.95萬股，成交價$26.0，涉資648.7萬

阿斯达克财经

康龍化成取得高效液相色譜柱清洗裝置專利，改善清洗液利用效率較低的問題

CRO指數盤中漲幅擴大至3%，美迪西漲停，昭衍新藥、畢得醫藥、陽光諾和、益諾思跟漲。

泰格醫藥盤中異動急速拉昇5.03%

昭衍新藥盤中異動早盤大幅上漲5.05%報20.400港元

敬告客戶-以下稿子現予以撤銷-美國議員再次關注 GenScript 與中國的關係

藥明生物(02269.HK)7月8日耗資3億港元回購1168萬股

【藥明生物(02269.HK)7月8日斥資2.99億港元回購1168萬股】智通財經APP訊，藥明生物(02269.HK)

生物科技復興有望？藥明康德CRDMO模式加速歐洲創新進程

港交所文件顯示，貝萊德H股持倉比例從7月2日的5.49%降至4.98%

上海萊士：SR604注射液進入Ⅱb期臨牀試驗研究

上海萊士(002252.SZ)：SR604注射液進入Ⅱb期臨牀試驗研究

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2233.9766,"timestamp":1752808942529,"preClose":2234.6729,"halted":0,"volume":60472164,"delay":0,"changeRate":-0.000312,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-0.696289,"latestTime":"07-18 11:22:23","open":2235.1245,"high":2278.2698,"low":2232.6262,"amount":1630979295,"amplitude":0.020425,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1752811200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"pbRate":2.645062,"peRate":12.62363,"turnoverRate":0.005333,"increases":5,"decrements":2,"flats":1,"marketCap":512604910080,"floatMarketCap":206863095296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2278.2698,"amplitude":0.020425,"preClose":2234.6729,"low":2232.6262,"pbRate":"2.645062","latestPrice":2233.9766,"volume":60472164,"delay":0,"open":2235.1245,"prevYearClose":1395.7731,"prevWeekClose":2104.475,"prevMonthClose":1988.255,"prevQuarterClose":1988.255,"fiveDayClose":2104.475,"twentyDayClose":1884.191,"sixtyDayClose":1574.66,"secType":"PLATE","market":"HK","turnoverRate":0.005333,"peRate":12.62363,"marketCap":512604910080,"floatMarketCap":206863095296,"timestamp":1752808942529,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":5,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550069684","title":"復星醫藥子公司啓動復邁寧®兒童腦膠質瘤Ⅲ期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069684","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550069684?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:37","pubTimestamp":1752050252,"startTime":"0","endTime":"0","summary":"7月9日，复星医药发布公告，控股子公司药品临床试验进展情况。公告指出，该公司控股子公司上海复星医药产业发展有限公司已启动复迈宁用于治疗儿童低级别脑胶质瘤的Ⅲ期临床试验。与此同时，该药品用于成人Ⅰ型神经纤维瘤病和儿童低级别脑胶质瘤的临床试验均处于Ⅲ期阶段，涉及的其他适应症也在进行相关临床试验。2025年一季度，复星医药实现收入94.20亿元，归母净利润7.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709163825953bec38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709163825953bec38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02196","BK1576","BK1515","BK1191","BK1583","03347","BK1593"],"gpt_icon":0},{"id":"2550638236","title":"每日賣空追蹤 | 康龍化成 07月09日賣空量成交15.08萬股，賣空比例為1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550638236?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:30","pubTimestamp":1752049835,"startTime":"0","endTime":"0","summary":"康龙化成北京时间07月09日，涨0.24%，卖空量成交15.08万股%，较上一交易日减少24.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172604a69f1a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172604a69f1a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2550635939","title":"每日賣空追蹤 | 泰格醫藥 07月09日賣空量成交85.54萬股，賣空比例為7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550635939?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:30","pubTimestamp":1752049834,"startTime":"0","endTime":"0","summary":"泰格医药北京时间07月09日，涨6.75%，卖空量成交85.54万股%，较上一交易日增加18.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172543a440060d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172543a440060d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03347","BK1141","BK1576"],"gpt_icon":0},{"id":"2550638454","title":"每日賣空追蹤 | 藥明生物 07月09日賣空量成交489.7萬股，賣空比例為12.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550638454?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:30","pubTimestamp":1752049830,"startTime":"0","endTime":"0","summary":"药明生物北京时间07月09日，涨0.78%，卖空量成交489.7万股%，较上一交易日减少10.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172412a69f199b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172412a69f199b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0348825331.USD","LU1720050803.USD","BK1576","IE00B0JY6N72.USD","LU0359201612.USD","LU0856984785.SGD","LU0039217434.USD","LU1688375341.USD","LU0456846285.SGD","LU0052750758.USD","LU0326950275.SGD","LU0516422366.SGD","LU0417516738.SGD","LU0823426308.USD","LU0823426480.USD","LU0588546209.SGD","LU1242518931.SGD","LU0516422952.EUR","02269","LU0456827905.SGD","LU0307460666.USD","LU1880383366.USD","LU0140636845.USD","LU0516423174.USD","LU0572944931.SGD","LU0051755006.USD","LU0348735423.USD","LU1242518857.USD","LU0979878070.USD","LU0181495838.USD","SG9999002463.SGD","LU0320764599.SGD","LU0043850808.USD","LU2039709279.SGD","BK1589","LU0708995583.HKD","LU0516422440.USD","BK1610","LU1794554557.SGD","LU0359202008.SGD","BK1521","SG9999002562.SGD","LU0417516902.SGD","LU0327786744.USD","LU0516423091.SGD","LU0819121731.USD"],"gpt_icon":0},{"id":"2550635608","title":"每日賣空追蹤 | 藥明康德 07月09日賣空量成交38.06萬股，賣空比例為9.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550635608?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:30","pubTimestamp":1752049830,"startTime":"0","endTime":"0","summary":"药明康德北京时间07月09日，跌1.19%，卖空量成交38.06万股%，较上一交易日增加18.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172426a4400557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172426a4400557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","LU0052750758.USD","02359","LU2045819591.USD","BK1576","LU2125910500.SGD","LU0320764599.SGD","BK1583","LU1046422090.SGD","LU2242644610.SGD","BK1141"],"gpt_icon":0},{"id":"2550162638","title":"每日賣空追蹤 | 金斯瑞生物科技 07月09日賣空量成交264.6萬股，賣空比例為5.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550162638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550162638?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:30","pubTimestamp":1752049823,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技北京时间07月09日，涨3.5%，卖空量成交264.6万股%，较上一交易日增加16.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172208a440040e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172208a440040e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","01548","BK1583","HK0000320264.USD","BK1141","BK1576","HK0000306701.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2550568013","title":"維亞生物07月09日獲主力加倉59.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550568013","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550568013?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:15","pubTimestamp":1752048945,"startTime":"0","endTime":"0","summary":"07月09日, 维亚生物股价涨1.39%，报收1.46元，成交金额493.8万元，换手率0.16%，振幅5.56%，量比0.37。维亚生物今日主力资金净流入59.9万元，连续4日净流入，上一交易日主力净流入98.1万元。该股近5个交易日下跌4.61%，主力资金累计净流入9.8万元；近20日主力资金累计净流出976.4万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170144a43ff565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170144a43ff565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"2550341689","title":"微芯生物(688321.SH)：西達本胺一線治療瀰漫大B細胞淋巴瘤的III期臨牀試驗獲頂線分析數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2550341689","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550341689?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 16:02","pubTimestamp":1752048130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微芯生物 公告，公司自主研发的西达本胺针对一线治疗弥漫大B细胞淋巴瘤关键性III期临床试验已于近日获得最终结果的顶线分析数据，试验组无事件生存期显著优于对照组，达成研究主要终点。西达本胺作用于表观遗传相关靶点组蛋白去乙酰化酶。此次顶线分析中，试验组无事件生存期较对照组展现具统计学显著意义的差异，进一步验证了西达本胺联合方案可为初治MYC和BCL2双表达DLBCL患者带来显著且可持续的疗效，且安全性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK1583","BK4134","BK1576","688321","BK1141","BK0239","03347"],"gpt_icon":0},{"id":"2550500075","title":"藥明生物(02269)出現大手賣出24.95萬股，成交價$26.0，涉資648.7萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2550500075","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550500075?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 14:19","pubTimestamp":1752041940,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午02:19出现大手卖出，成交量为24.95万，成交价为港币$26.0，涉资648.7万。至目前为止，股价升1.362%，今日最高价为$26.2，而最低价为$25.3，总成交量为2.709千万股，总成交金额港币$7.002亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2507094930/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0708995583.HKD","LU0307460666.USD","BK1576","LU0823426308.USD","LU0326950275.SGD","LU1688375341.USD","LU0819121731.USD","LU0039217434.USD","BK1610","LU0051755006.USD","LU0979878070.USD","LU0140636845.USD","SG9999002562.SGD","BK1521","LU0348735423.USD","LU1720050803.USD","LU0572944931.SGD","LU0516423091.SGD","LU1880383366.USD","LU0359202008.SGD","LU0043850808.USD","LU0417516902.SGD","LU0516422366.SGD","LU0516422440.USD","LU0052750758.USD","LU0359201612.USD","LU0856984785.SGD","LU0516422952.EUR","LU0516423174.USD","BK1589","LU1242518931.SGD","SG9999002463.SGD","LU1242518857.USD","02269","LU0588546209.SGD","LU0417516738.SGD","LU0348825331.USD","LU0320764599.SGD","LU0456827905.SGD","LU1794554557.SGD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0327786744.USD","LU0456846285.SGD","LU0181495838.USD","LU0823426480.USD","BK1141"],"gpt_icon":0},{"id":"2550020502","title":"康龍化成取得高效液相色譜柱清洗裝置專利，改善清洗液利用效率較低的問題","url":"https://stock-news.laohu8.com/highlight/detail?id=2550020502","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550020502?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 12:52","pubTimestamp":1752036752,"startTime":"0","endTime":"0","summary":"金融界2025年7月9日消息，国家知识产权局信息显示，康龙化成 药物开发有限公司取得一项名为“一种高效液相色谱柱清洗装置”的专利，授权公告号CN223070086U，申请日期为2024年08月。天眼查资料显示，康龙化成（宁波）药物开发有限公司，成立于2018年，位于宁波市，是一家以从事研究和试验发展为主的企业。通过天眼查大数据分析，康龙化成（宁波）药物开发有限公司参与招投标项目9次，专利信息8条，此外企业还拥有行政许可20个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709130420953bb816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709130420953bb816&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03759","BK1576"],"gpt_icon":0},{"id":"2550506101","title":"CRO指數盤中漲幅擴大至3%，美迪西漲停，昭衍新藥、畢得醫藥、陽光諾和、益諾思跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506101","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550506101?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 11:05","pubTimestamp":1752030351,"startTime":"0","endTime":"0","summary":"CRO指数盘中涨幅扩大至3%，美迪西涨停，昭衍新药、毕得医药、阳光诺和、益诺思跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/09110551578183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603127","688710","06127","688073","688202","BK1576","BK0216","688621","BK1141"],"gpt_icon":0},{"id":"2550505560","title":"泰格醫藥盤中異動 急速拉昇5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550505560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550505560?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 10:30","pubTimestamp":1752028256,"startTime":"0","endTime":"0","summary":"2025年07月09日早盘10时30分，泰格医药股票出现异动，股价大幅拉升5.03%。截至发稿，该股报45.900港元/股，成交量412.67万股，换手率3.35%，振幅6.64%。机构评级方面，在所有13家参与评级的机构中，62%的券商给予买入建议，23%的券商给予持有建议，15%的券商给予卖出建议。泰格医药股票所在的生物技术行业中，整体涨幅为0.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709103056a43f3312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709103056a43f3312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2550055995","title":"昭衍新藥盤中異動 早盤大幅上漲5.05%報20.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550055995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550055995?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 10:26","pubTimestamp":1752027998,"startTime":"0","endTime":"0","summary":"2025年07月09日早盘10时26分，昭衍新药股票出现异动，股价大幅拉升5.05%。截至发稿，该股报20.400港元/股，成交量334.957万股，换手率2.81%，振幅8.08%。资金方面，该股资金流入2886.75万港元，流出2312.79万港元。最近的财报数据显示，该股实现营业收入3.11亿港元，净利润4,455.80万港元，每股收益0.0542港元，毛利8,907.85万港元，市盈率191.14倍。昭衍新药股票所在的生物技术行业中，整体涨幅为1.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102638a43f30a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102638a43f30a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2550575453","title":"敬告客戶-以下稿子現予以撤銷-美國議員再次關注 GenScript 與中國的關係","url":"https://stock-news.laohu8.com/highlight/detail?id=2550575453","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550575453?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 05:30","pubTimestamp":1752010205,"startTime":"0","endTime":"0","summary":"敬告客户-以下稿子现予以撤销-美国议员再次关注 GenScript 与中国的关系STORY_NUMBER: L4T3T51DESTORY_DATE: 08/07/2025STORY_TIME: 2130 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL4T3T51DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","HK0000306685.HKD","BK1141","HK0000306701.USD","HK0000320223.HKD","BK4588","01548","BK1583","BK1576","HK0000320264.USD","BK4585","LEGN"],"gpt_icon":0},{"id":"2549531540","title":"藥明生物(02269.HK)7月8日耗資3億港元回購1168萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549531540","media":"格隆汇","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549531540?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 21:08","pubTimestamp":1751980085,"startTime":"0","endTime":"0","summary":"格隆汇7月8日丨药明生物(02269.HK)公告，7月8日耗资3亿港元回购1168万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08210851569366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0052750758.USD","LU0823426480.USD","LU0516422440.USD","BK1521","BK1141","LU0307460666.USD","SG9999002463.SGD","LU1242518857.USD","LU1242518931.SGD","LU0456827905.SGD","LU0348735423.USD","LU0039217434.USD","02269","LU0572944931.SGD","LU0823426308.USD","LU0588546209.SGD","LU0359202008.SGD","LU0819121731.USD","LU0327786744.USD","LU0326950275.SGD","LU0359201612.USD","LU0348825331.USD","LU0516423091.SGD","LU0856984785.SGD","LU1720050803.USD","LU1880383366.USD","LU0979878070.USD","LU0140636845.USD","LU0417516738.SGD","LU0456846285.SGD","SG9999002562.SGD","BK1610","LU0417516902.SGD","LU0516423174.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU1688375341.USD","LU0516422366.SGD","BK1576","LU1794554557.SGD","LU2039709279.SGD","LU0051755006.USD","BK1589","LU0516422952.EUR","LU0320764599.SGD","LU0708995583.HKD","LU0181495838.USD"],"gpt_icon":0},{"id":"2549540892","title":"【藥明生物(02269.HK)7月8日斥資2.99億港元回購1168萬股】智通財經APP訊，藥明生物(02269.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549540892","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549540892?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 21:05","pubTimestamp":1751979904,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516422952.EUR","BK1521","LU0823426308.USD","BK1576","LU1720050803.USD","LU0516423174.USD","LU2039709279.SGD","LU0588546209.SGD","LU0456827905.SGD","LU1794554557.SGD","LU0456846285.SGD","SG9999002562.SGD","BK1610","LU0359202008.SGD","LU0516422440.USD","LU1242518857.USD","02269","LU0051755006.USD","LU0823426480.USD","SG9999002463.SGD","LU0052750758.USD","LU0307460666.USD","LU0979878070.USD","LU0819121731.USD","LU0359201612.USD","LU0348735423.USD","LU0417516738.SGD","BK1589","LU0140636845.USD","LU0327786744.USD","LU0417516902.SGD","LU0572944931.SGD","LU0181495838.USD","LU1880383366.USD","LU0516422366.SGD","LU1242518931.SGD","LU0320764599.SGD","BK1141","LU0516423091.SGD","LU0326950275.SGD","LU0043850808.USD","LU0856984785.SGD","LU0348825331.USD","LU0708995583.HKD","LU0039217434.USD","LU1688375341.USD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2549154145","title":"生物科技復興有望？藥明康德CRDMO模式加速歐洲創新進程","url":"https://stock-news.laohu8.com/highlight/detail?id=2549154145","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549154145?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 19:13","pubTimestamp":1751973228,"startTime":"0","endTime":"0","summary":"药明康德“一站式、端到端”的CRDMO模式能够提供覆盖药物开发完整价值链的能力、技术和规模设施，显著降低了Biotech在工艺开发、监管合规和产能供应等方面的风险。通过与药明康德合作，这家公司不仅能获得高效的执行落地能力，还能吸收关键的产业化经验，从而加速新药研发进程。2025年第一季度，药明康德的小分子D&M管线新增了203个分子，其中R到D转化的分子有75个，充分体现了CRDMO平台在分子转化上的优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708192508a69d17a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708192508a69d17a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2045819591.USD","LU2125910500.SGD","603259","BK1141","LU0320764599.SGD","BK1583","02359","BK1576","LU1046422090.SGD","LU2242644610.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2549545901","title":"港交所文件顯示，貝萊德H股持倉比例從7月2日的5.49%降至4.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549545901","media":"金十数据","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549545901?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 18:13","pubTimestamp":1751969628,"startTime":"0","endTime":"0","summary":"港交所文件显示， 贝莱德 (BLK.N)在 药明康德 (02359.HK)H股持仓比例从7月2日的5.49%降至4.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708181908a69cf7e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708181908a69cf7e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU2242644610.SGD","LU1046422090.SGD","80388","BLK","02359","00388","BK1141","LU0708995583.HKD","BK1131","LU2125910500.SGD","BK1583","LU2045819591.USD","LU0052750758.USD"],"gpt_icon":0},{"id":"2549458095","title":"上海萊士：SR604注射液進入Ⅱb期臨牀試驗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2549458095","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549458095?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 18:09","pubTimestamp":1751969396,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","BK1576","BK0239","BK0028","03347","002252","BK0196","BK0188","BK1141","BK1583"],"gpt_icon":0},{"id":"2549545314","title":"上海萊士(002252.SZ)：SR604注射液進入Ⅱb期臨牀試驗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2549545314","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549545314?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 18:07","pubTimestamp":1751969270,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海莱士 公告，公司近日在国家药品监督管理局药物临床试验登记与信息公示平台公示了IIb期临床试验登记信息，试验名称为：评价SR604注射液在血友病A/B及先天性凝血因子Ⅶ缺乏症患者中的安全性、耐受性、有效性、PK/PD特征的开放、多中心Ⅰ/Ⅱ期临床试验。据公告所示，SR604注射液拟用于血友病A/B及先天性凝血因子Ⅶ缺乏症患者出血的预防治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1141","BK0196","002252","BK0046","BK1576","BK1583","03347","BK0028","BK0188"],"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":9,"totalSize":248,"code":"91000000","status":"200"}]}}